Peer Review reports
From: The impact of cathelicidin, the human antimicrobial peptide LL-37 in urinary tract infections
| Original Submission | ||
|---|---|---|
| 1 Mar 2017 | Submitted | Original manuscript |
| 23 May 2017 | Author responded | Author comments - Ibrahim Babikir |
| Resubmission - Version 2 | ||
| 23 May 2017 | Submitted | Manuscript version 2 |
| 26 Jul 2017 | Reviewed | Reviewer Report - David Hains |
| 2 Aug 2017 | Author responded | Author comments - Ibrahim Babikir |
| Resubmission - Version 3 | ||
| 2 Aug 2017 | Submitted | Manuscript version 3 |
| 22 Sep 2017 | Reviewed | Reviewer Report - David Hains |
| 8 Nov 2017 | Author responded | Author comments - Ibrahim Babikir |
| Resubmission - Version 4 | ||
| 8 Nov 2017 | Submitted | Manuscript version 4 |
| 3 Dec 2017 | Author responded | Author comments - Ibrahim Babikir |
| Resubmission - Version 5 | ||
| 3 Dec 2017 | Submitted | Manuscript version 5 |
| Publishing | ||
| 10 Dec 2017 | Editorially accepted | |
| 8 Jan 2018 | Article published | 10.1186/s12879-017-2901-z |
You can find further information about peer review here.